Loading...
•
Mar 31, 2024
Revvity Q1 2024 Earnings Report
Revvity reported a revenue of $650 million with a (4)% reported growth and GAAP EPS of $0.21.
Key Takeaways
Revvity announced its financial results for the first quarter of 2024, reporting a revenue of $650 million. The company's GAAP EPS was $0.21, and the adjusted EPS from continuing operations was $0.98. Revvity reaffirmed its full-year 2024 organic growth and adjusted EPS guidance.
Revenue of $650 million; (4)% reported growth; (3)% organic growth
First quarter GAAP EPS of $0.21; Adjusted EPS from continuing operations of $0.98
Reaffirms full year 2024 organic growth and adjusted EPS guidance
Life Sciences revenue was $303 million, a decrease of 8% year-over-year.
Diagnostics revenue was $347 million, flat year-over-year.
Revenue by Segment
Forward Guidance
The Company is updating its full year 2024 total revenue guidance to a range of $2.76-$2.82 billion to reflect recent changes in foreign currency exchange rates. The Company is also reaffirming its adjusted EPS guidance of $4.55-$4.75 and organic growth guidance of 1-3%.
Revenue & Expenses
Visualization of income flow from segment revenue to net income
Historical Earnings Impact
Analyze how earnings announcements historically affect stock price performance
Avg. Return Before/After Earnings
Loading earnings performance data...
Loading earnings reaction data...